Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients
NCT02294292Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in Cirrhosis and diastolic dysfunction (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Progression of cirrhosis and its complications at 1 year. Started Jul 2014; status: completed.
02
Drugs
carvedilol
03
Conditions
Cirrhosisdiastolic dysfunction
Beyond the preview
Go deeper on NCT02294292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294292.